62 related articles for article (PubMed ID: 7834116)
1. Influence of biological response modifiers: measurement of tumor blood flow and temperature.
Li J; Merton DA; Thakur ML; Barr J; Wilder S; O'Hara MD; Gibbons G; Goldberg B
J Immunother Emphasis Tumor Immunol; 1994 Oct; 16(3):175-80. PubMed ID: 7834116
[TBL] [Abstract][Full Text] [Related]
2. Augmenting of tumor uptake of anti-melanoma antibody MEM136: influence of interferon.
Li J; Merton DA; Duggaraju R; Thakur ML
Nucl Med Biol; 1996 Oct; 23(7):873-9. PubMed ID: 8971854
[TBL] [Abstract][Full Text] [Related]
3. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
Bassukas ID; Hofmockel G; Maurer-Schultze B
Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
[TBL] [Abstract][Full Text] [Related]
4. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
Hines-Peralta A; Sukhatme V; Regan M; Signoretti S; Liu ZJ; Goldberg SN
Radiology; 2006 Jul; 240(1):82-9. PubMed ID: 16720872
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors.
Kluge M; Elger B; Engel T; Schaefer C; Seega J; Vaupel P
Cancer Res; 1992 Apr; 52(8):2167-73. PubMed ID: 1559220
[TBL] [Abstract][Full Text] [Related]
6. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha as angiogenesis inhibitor: learning from tumor models.
Indraccolo S
Autoimmunity; 2010 Apr; 43(3):244-7. PubMed ID: 20166871
[TBL] [Abstract][Full Text] [Related]
8. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
[TBL] [Abstract][Full Text] [Related]
9. cis-3, 4', 5-Trimethoxy-3'-aminostilbene disrupts tumor vascular perfusion without damaging normal organ perfusion.
Durrant D; Corwin F; Simoni D; Zhao M; Rudek MA; Salloum FN; Kukreja RC; Fatouros PP; Lee RM
Cancer Chemother Pharmacol; 2009 Jan; 63(2):191-200. PubMed ID: 18365199
[TBL] [Abstract][Full Text] [Related]
10. [Effect of 131I-labeled recombinant human tumor necrosis factor-alpha on the nude mice bearing human hepatoma].
Long YH; Li YC; Mi YX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):787-92. PubMed ID: 19950584
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydralazine on the blood flow in RIF-1 tumors and normal tissues of mice.
Lin JC; Song CW
Radiat Res; 1990 Nov; 124(2):171-7. PubMed ID: 2247597
[TBL] [Abstract][Full Text] [Related]
12. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts.
Kallinowski F; Schlenger KH; Runkel S; Kloes M; Stohrer M; Okunieff P; Vaupel P
Cancer Res; 1989 Jul; 49(14):3759-64. PubMed ID: 2736517
[TBL] [Abstract][Full Text] [Related]
13. Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.
Maurer-Schultze B; Bassukas ID; Hofmockel G
Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):65-78. PubMed ID: 7773138
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice.
Kasuga Y; Matsubayashi S; Akasu F; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1991 Jun; 72(6):1296-301. PubMed ID: 1902846
[TBL] [Abstract][Full Text] [Related]
15. Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment.
Palmowski M; Huppert J; Hauff P; Reinhardt M; Schreiner K; Socher MA; Hallscheidt P; Kauffmann GW; Semmler W; Kiessling F
Cancer Res; 2008 Sep; 68(17):7042-9. PubMed ID: 18757418
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
17. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.
Longley C; Furmanski P; Dienhart DG; Lear J; Bloedow D; Kasliwal R; Bunn PA
Cancer Res; 1990 Sep; 50(18):5954-61. PubMed ID: 2393864
[TBL] [Abstract][Full Text] [Related]
19. [Biodistribution of radiolabeled F(ab')2 fragment of monoclonal antibody Nd2 and gamma-interferon enhancement on tumor localization in nude mice with human pancreatic tumor xenografts].
Kondo Y
Nihon Geka Gakkai Zasshi; 1995 Feb; 96(2):97-105. PubMed ID: 7708049
[TBL] [Abstract][Full Text] [Related]
20. A preclinical study to explore vasculature differences between primary and recurrent tumors using ultrasound Doppler imaging.
Chen JJ; Fu SY; Chiang CS; Hong JH; Yeh CK
Ultrasound Med Biol; 2013 May; 39(5):860-9. PubMed ID: 23415281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
